$91 Million is the total value of PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's 10 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEM | NEWMONT GOLDCORP CORPORATION | $21,609,000 | +36.4% | 350,000 | 0.0% | 23.74% | +39.4% | |
| GOLD | BARRICK GOLD CORPORATION | $13,470,000 | +47.1% | 500,000 | 0.0% | 14.80% | +50.4% | |
| EPSN | EPSILON ENERGY LTD | $3,201,000 | +10.5% | 1,085,000 | 0.0% | 3.52% | +13.0% | |
| IRIX | IRIDEX CORP | $2,798,000 | +33.3% | 1,320,000 | 0.0% | 3.07% | +36.3% | |
| ESXB | COMMUNITY BANKERS TR CORP | $1,375,000 | +13.4% | 250,000 | 0.0% | 1.51% | +15.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAVIGATOR HOLDINGS LTD | 40 | Q3 2023 | 38.2% |
| IRIDEX CORP | 40 | Q3 2023 | 23.4% |
| COMMUNITY BANKERS TR CORP | 28 | Q3 2020 | 10.5% |
| PAR PETROLEUM CORP | 26 | Q2 2020 | 15.3% |
| REATA PHARMACEUTICALS INC | 22 | Q3 2021 | 34.4% |
| EPSILON ENERGY LTD | 19 | Q3 2023 | 16.6% |
| CAREDX INC | 16 | Q2 2019 | 6.6% |
| FORESTAR GROUP INC | 16 | Q4 2019 | 3.0% |
| SPDR S&P 500 ETF TR | 13 | Q3 2022 | 34.2% |
| HOWARD HUGHES CORP | 13 | Q1 2019 | 5.5% |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Epsilon Energy Ltd. | June 12, 2023 | 900,000 | 3.9% |
| IRIDEX CORP | November 23, 2022 | 963,250 | 6.0% |
| CareDx, Inc. | January 24, 2018 | 1,133,000 | 3.9% |
| CASCADE MICROTECH INC | November 04, 2014 | 950,000 | 5.8% |
| SPECTRANETICS CORP | October 02, 2012 | 1,700,000 | 4.9% |
| DUSA PHARMACEUTICALS INC | May 26, 2011 | 1,218,500 | 5.0% |
| SENORX INC | May 07, 2010 | 140,993 | 0.8% |
| TRANSCOMMUNITY FINANCIAL CORP | March 21, 2008 | 445,000 | 9.7% |
| ARONEX PHARMACEUTICALS INC | January 25, 2000 | 1,138,111 | 5.0% |
| APPLIED IMAGING CORP | January 20, 2000 | 483,833 | 4.0% |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| SC 13D | 2022-11-23 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.